Rhythm Pharmaceuticals, Inc. (RYTM)
90.63
+3.42
(+3.92%)
USD |
NASDAQ |
May 20, 16:00
90.63
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Total Assets (Quarterly) : 442.32M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 66.48M |
| Sarepta Therapeutics, Inc. | 3.179B |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Biogen, Inc. | 29.48B |
| MannKind Corp. | 744.40M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 319.41M |
| Shareholders Equity (Quarterly) | 122.91M |
| Debt to Equity Ratio | 1.847 |
| Current Ratio | 4.168 |
| Net Debt Paydown Yield | 0.10% |